Medical Economical Evaluation of the Ablation by Catheter of the Atrial Tissue in the Treatment of AF (EVABLAF)

This study has been completed.
Sponsor:
Collaborator:
Institut National de la Santé Et de la Recherche Médicale, France
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT01183091
First received: August 16, 2010
Last updated: September 19, 2012
Last verified: September 2012
  Purpose

The atrial fibrillation is the most frequent confusions of the heart rhythm: his preValencia increases with the age, and the investigators consider that beyond 65 years, 5 % of the population is affected by this arrhythmia. It entails a greater risk of morbidity (thromboembolic accident and cardiac insufficiency) and of cardiovascular mortality (mortality increased by a factor 1,7 - 2) independents of the causal pathology or the associated risk factors. For all these reasons, it raises a real problem of public health.


Condition Intervention
Atrial Fibrillation
Procedure: Ablation of atrial fibrillation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Medical Economical Evaluation of the Ablation by Catheter of the Atrial Tissue in the Treatment of the Atrial Fibrillation

Resource links provided by NLM:


Further study details as provided by Assistance Publique - Hôpitaux de Paris:

Primary Outcome Measures:
  • Success of ablation [ Time Frame: after 3 months ] [ Designated as safety issue: No ]
    The principal criterion of the medical evaluation is the success of ablation defined by the absence of repetition of AF (or the persistence of the sinusal rhythm) after the 3 months period following the procedures of ablation based on ECG or holter registration. These patients are likely to be able to profit from another procedure of ablation so necessary.


Enrollment: 503
Study Start Date: April 2005
Study Completion Date: October 2010
Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
First AF ablation
Description of the patients experiencing an AF ablation
Procedure: Ablation of atrial fibrillation
Ablation of atrial fibrillation

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 79 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Description of the patients experiencing a first AF ablation

Criteria

Inclusion Criteria:

  • Nonspontaneous and ≤90 days) symptomatic and dating of more than 6 months
  • Patient in failure of at least 1 antiarrythmic major (Class Ic or amiodarone) or repeats after at least 1 medicamentous or electric reduction
  • Patient having presented at least 1 episode of F documented by ECG or Holter
  • Patient having a medical history of AF which can be reconstituted retrospectively over the last 12 months
  • Patient currently under anticoagulant treatment by AVK balanced

Exclusion Criteria:

  • Patient presenting asymptomatic AF
  • Patient presenting AF permanent (90 days)
  • Patient presenting a counter-indication at the anticoagulants by oral way
  • Patient presenting of the antecedents of ablation of AF
  • Patient presenting an intracardiac thrombus
  • Patient presenting reversible AF of cause
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01183091

Locations
France
Service de cardiologie - Hôpital Lariboisière
Paris, France, 75010
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France
Investigators
Principal Investigator: Antoine LEENHARDT, MD,PhD Assistance Publique - Hôpitaux de Paris
  More Information

No publications provided

Responsible Party: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT01183091     History of Changes
Other Study ID Numbers: P040411
Study First Received: August 16, 2010
Last Updated: September 19, 2012
Health Authority: France: Ministry of Health

Keywords provided by Assistance Publique - Hôpitaux de Paris:
Atrial fibrillation
Ablation

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on July 26, 2014